Navigation Links
Unigene Reports Third Quarter 2011 Financial Results
Date:11/9/2011

BOONTON, N.J., Nov. 9, 2011 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics, announced third quarter financial results for the period ended September 30, 2011. The Company continued solid execution of its turnaround strategy and highlighted significant progress achieved in the third quarter.

Ashleigh Palmer, Unigene's President and CEO stated, "We have made tremendous progress in the past nine months and are poised to complete the successful turnaround of Unigene as we end 2011.  We maintain clear focus on the solid execution of our targeted growth strategy and are confident Unigene and its shareholders will benefit from the multiple near-term game changing events anticipated in the coming year." Third Quarter 2011 Highlights

  • Entered Development Services and Clinical Supply Agreement with GlaxoSmithKline (GSK) in preparation of potential Phase 3 study of oral parathyroid hormone (PTH);
  • Positive Phase 3 safety and efficacy results for Unigene's oral calcitonin product, licensed to Tarsa Therapeutics, further validated industry leading oral peptide and recombinant manufacturing technology platforms;
  • Divested non-core asset to focus resources on high valuation drug development and peptide drug delivery opportunities by assigning Site Directed Bone Growth (SDBG) to leading researcher; and
  • Appointed industry veteran, Theron (Ted) Odlaug to Board of Directors.

  • Highlights Subsequent to Quarter End

  • Completed all patient dosing in Phase 2 study of oral PTH;
  • Unigene and Nordic Bioscience combine their industry leading capabilities to advance Unigene's proprietary peptides through Phase 2 proof-of-concept for multiple blockbuster indications, including diabetes; and
  • Peptide development expertise endorsed with a strategic equity investment from industry legend, Dr. Claus Chr
    '/>"/>

  • SOURCE Unigene Laboratories, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
    2. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
    3. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
    4. GenVec Reports Third Quarter 2011 Financial Results
    5. Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011
    6. Allied Healthcare Products Reports First Quarter Loss on Sales Decline
    7. ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis
    8. Stereotaxis Reports Third Quarter Financial Results
    9. Isis Reports Financial Results and Highlights for Third Quarter 2011
    10. Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
    11. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... -- Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator ... imaging centers in China , ... under which Concord Medical Services (International) Pte Ltd, ... to acquire the Fortis Surgical Hospital from Fortis ...
    (Date:3/26/2015)... -- The Burzynski Research Institute, Inc. (BRI) announced today that ... Department of Surgery at Kurume University Medical Center ... published. The study, a randomized non-blinded phase 2 ... adjuvant therapy with and without Antineoplastons A10/AS2-1 Injections ... A total of 65 patients, with histologically ...
    (Date:3/26/2015)... Calif. , March 26, 2015 Huntington ... Gabriel Valley to perform transcatheter aortic valve replacement (TAVR), ... procedure is a revolutionary new way to replace an ... of a heart lung machine. The procedure ... team led by Azhil ( Alex) Durairaj , MD, ...
    Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
    ... , EXTON, Pa., Nov. 23 ... LaunchTrends (TM): Feraheme report, the second ... AMAG,s new IV iron product, Feraheme, through the first six months ... information from 50 unique Nephrologists and qualitative information from a subset ...
    ... , FORT WORTH, Texas, Nov. 23 ... of specialty medical products, announced that it has filed it Q3 2009 ... the developments during the 2009 calendar year. , Q3 2009 sales ... , Shareholder equity as of the Q3 2009 increased to $3,327,892 ...
    Cached Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 6
    (Date:3/28/2015)... Purity Products®, a leading direct to ... of their revolutionary new weight loss product, MuffinStop™. ... placebo-controlled clinical studies to be effective in reducing ... is a combination of two traditionally used botanical ... to create one of the most innovative weight ...
    (Date:3/28/2015)... LTW Cyber is an innovation hub ... the purpose of addressing the needs of the global ... own opportunities to grow while seeking collaborative opportunities with ... , Ventures in LTW Cyber focus on secure application ... identifying vulnerabilities and analyzing open source. As the ...
    (Date:3/27/2015)... Island, NY (PRWEB) March 27, 2015 ... cancer-focused training and business criteria for the spa and ... services to clients who have experienced or are living ... the global Spafinder Wellness 365® Network, will be identified ... and recognized as a provider of safe, therapeutic services ...
    (Date:3/27/2015)... Florida Hospital is excited to continue its partnership with ... provider for the 2015 and 2016 season. As the Storm’s ... an athletic trainer for the team throughout each season. Tonight, ... the Cleveland Gladiators at Amalie Arena; the game starts at ... us as it gives us the opportunity, to provide health ...
    (Date:3/27/2015)... Texas (PRWEB) March 27, 2015 First ... 7am today. The new facility is located 12665 W Lake ... “As a resident of Summerwood, I look forward to delivering ... said Dr. Sowell, Facility Medical Director of First Choice Emergency ... Choice Emergency Room made a donation to Summer Creek High ...
    Breaking Medicine News(10 mins):Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 2Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 3Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
    ... patients, according to a recent study, are increasingly turning ... In this context physicians need to be aware of ... patients to the most reliable, accurate and updated information. ... Cancer Center in Philadelphia echoed these ideas at the ...
    ... Dr. Balakrishna Ganapat Rao Matapurkar, from Maulana Azad Medical ... winning the first patent on organ regeneration from the ... / repairing organs in human beings. ,A few ... patent on this technique. Dr. Matapurkar was able ...
    ... has come out with a damning disclosure that half the ... Tobacco Day 2001," World Health Organization chief Gro Harlem Brundtland ... because most governments still allowed smoking in public places. She ... no safe permissible levels of second hand smoke. ,"Far ...
    ... Pfizer on the Indian front has run into rough ... subsidiary Parke-Davis (India). A local court in Hyderabad ... the city. ,The vacation court of the Ranga ... and machinery of Parke-Davis (India) following a petition filed ...
    ... forward by Brazil, at the annual assembly of the ... breast-feeding for the first six months in all infants. ... on Wednesday after 2 hours of debate where many ... for breast-feeding. ,Nestle, a maker of infant formula ...
    ... reproductive scientists plan to launch a human cloning clinic, ... 18 months, according to a US infertility specialist, Dr. ... Univeristy of Kentucky, is not medically qualified but holds ... and director of two USD infertility clinics, the Kentucky ...
    Cached Medicine News:Health News:Scientists plan human cloning clinic in the United States 2
    ... automated 100-position ESR analyzer designed for laboratories ... instrument accurately and precisely measures the sedimentation ... ESR-Vacuum Tubes. Results are measured in millimeters ... available in 30 minutes. The ESR-100 features ...
    ... Sysmex CA-1500 enhances productivity in the laboratory ... three detection methods clotting, chromogenic and ... and precise test results every time. ... options and random access, the CA-1500 will ...
    ... Qwik-Let Elite has become one of ... This popularity is due to the ... in the design and function of ... device is priced for far less ...
    This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,410-0) or contact custom...
    Medicine Products: